Heidbreder, Christian

The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics

Heidbreder, C. A., & Groenewegen, H. J. (2003) · Neuroscience & Biobehavioral Reviews

Neural and Behavioral Psychology StudiesNeurotransmitter Receptor Influence on Behavior

Cited by 882

Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome

Heidbreder, C. A., Weiss, I. C., Domeney, A. M., Pryce, C., Homberg, J., Hedou, G., Feldon, J., Moran, M. C., & Nelson, P. (2000) · Neuroscience

Stress Responses and CortisolNeurotransmitter Receptor Influence on Behavior

Cited by 404

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Haight, B. R., Learned, S. M., Laffont, C. M., Fudala, P. J., Zhao, Y., Garofalo, A. S., Greenwald, M. K., Nadipelli, V. R., Ling, W., Heidbreder, C., et al. (2019) · The Lancet

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 285

Cytoskeletal changes in the hippocampus following restraint stress. Role of serotonin and microtubules

Bianchi, M., Heidbreder, C., & Crespi, F. (2003) · Synapse

Stress Responses and CortisolTreatment of Major Depression

Cited by 72

Pharmacological modulation of functional connectivity: the correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A

Schwarz, A. J., Gozzi, A., Reese, T., Heidbreder, C. A., & Bifone, A. (2007) · Magnetic Resonance Imaging

Neurotransmitter Receptor Influence on BehaviorFunctional Brain Connectivity Studies

Cited by 68

Fluoxetine administration modulates the cytoskeletal microtubular system in the rat hippocampus

Bianchi, M., Shah, A. J., Fone, K. C. F., Atkins, A. R., Dawson, L. A., Heidbreder, C. A., Hows, M. E., Hagan, J. J., & Marsden, C. A. (2009) · Synapse

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 56

A model‐based approach to characterize the population pharmacokinetics and the relationship between the pharmacokinetic and safety profiles of RBP‐7000, a new, long‐acting, sustained‐released formulation of risperidone

Gomeni, R., Heidbreder, C., Fudala, P. J., & Nasser, A. F. (2013) · The Journal of Clinical Pharmacology

Schizophrenia research and treatmentPharmaceutical studies and practices

Cited by 38

Population Pharmacokinetics and Prediction of Dopamine D2 Receptor Occupancy After Multiple Doses of RBP‐7000, a New Sustained‐Release Formulation of Risperidone, in Schizophrenia Patients on Stable Oral Risperidone Treatment

Laffont, C. M., Gomeni, R., Zheng, B., Heidbreder, C., Fudala, P. J., & Nasser, A. F. (2014) · Clinical Pharmacokinetics

Schizophrenia research and treatmentPharmaceutical studies and practices

Cited by 35

Population pharmacokinetic modeling and simulation to guide dose selection for RBP‐7000, a new sustained‐release formulation of risperidone

Laffont, C. M., Gomeni, R., Zheng, B., Heidbreder, C., Fudala, P. J., & Nasser, A. F. (2015) · The Journal of Clinical Pharmacology

Schizophrenia research and treatmentPharmaceutical studies and practices

Cited by 26